Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Rabbit Anti-Rat IgG(H+L), Human ads-FITC

Cat. No.:
Rabbit Anti-Rat IgG(H+L)-FITC antibody with minimal reactivity to human proteins for use in immunohistochemistry and other fluorescent assays.
Size Price (USD) Quantity
1.0 mg $94.00
More Information
Isotype Rabbit IgG
Isotype Control Rabbit IgG-FITC
Specificity Reacts with the heavy and light chains of rat IgG and the light chains of rat IgM
Source Pooled antisera from rabbits hyperimmunized with rat IgG
Cross Adsorption Human immunoglobulins and pooled sera; may react with immunoglobulins from other species and the light chains of other rat immunoglobulins
Purification Method Affinity chromatography on rat IgG covalently linked to agarose
Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Polyclonal
Concentration 1.0 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Applications Quality tested applications for relevant formats include -

Other referenced applications for relevant formats include -
Immunohistochemistry-Frozen Sections 2,3
Immunohistochemistry-Paraffin Sections 4
RRID Number AB_2796260

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Novitzky N, Davison G, Abdulla R, Mowla S. Definition of the variables affecting efficacy of immunodepletion ex vivo of peripheral blood progenitor cell grafts by alemtuzumab (Campath in the bag). Biol Blood Marrow Transplant. 2013;19:1753-9. (ELISA)
  2. 2. Fang Y, Xu C, Fu Y, Holers VM, Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol. 1998;160:5273-9. (IHC-FS)
  3. 3. Mao D, Wu X, Deppong C, Friend LD, Dolecki G, Nelson DM, et al. Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity. 2003;19:813-22. (IHC-FS)
  4. 4. SouthernBiotech published data (IHC-PS)